Unichem Laboratories is currently trading at Rs. 213.50, up by 1.45 points or 0.68 % from its previous closing of Rs. 212.05 on the BSE.
The scrip opened at Rs. 213.30 and has touched a high and low of Rs. 218.65 and Rs. 206.75 respectively. So far 60964 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 225.45 on 16-Jan-2014 and a 52 week low of Rs. 138.00 on 07-Aug-2013.
Last one week high and low of the scrip stood at Rs. 225.45 and Rs. 203.05 respectively. The current market cap of the company is Rs. 1924.45 crore.
The promoters holding in the company stood at 50.23 % while Institutions and Non-Institutions held 15.28 % and 34.48 % respectively.
Unichem Laboratories has received ANDA approval from the United States Food and Drug Administration (U.S. FDA) for Metronidazole USP Tablets.Metronidazole USP Tablets 250mg and 500mg are therapeutically equivalent to Flagyl Tablets 250mg and 500mg of G.D Searle LLC. Metronidazole Tablet USP is an anti-infective agent used to treat a variety of bacterial and protozoal infections.
The product will be commercialized from Unichem's Ghaziabad plant. Active pharmaceutical ingredient i.e., Metronidazole used for this ANDA is also made in house at Roha plant. Currently, around 6 other companies have generic approvals for the US market and the estimated market size is over $ 100 Million.
Unichem Laboratories is engaged in manufacturing formulations, pharmaceuticals and active pharmaceutical ingredients (APIs).
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1861.70 |
Dr. Reddys Lab | 1389.35 |
Cipla | 1506.15 |
Lupin | 2228.00 |
Zydus Lifesciences | 972.70 |
View more.. |